What is the share price of Genesis IBRC India Ltd (GENESIS) today?
The share price of GENESIS as on 18th July 2025 is ₹24.55. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Genesis IBRC India Ltd (GENESIS) share?
The past returns of Genesis IBRC India Ltd (GENESIS) share are- Past 1 week: N/A%
- Past 1 month: 10.23%
- Past 3 months: 33.86%
- Past 6 months: 40.53%
- Past 1 year: 62.58%
- Past 3 years: 151.54%
- Past 5 years: 262.09%
What are the peers or stocks similar to Genesis IBRC India Ltd (GENESIS)?
The peers or stocks similar to Genesis IBRC India Ltd (GENESIS) include:What is the market cap of Genesis IBRC India Ltd (GENESIS) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Genesis IBRC India Ltd (GENESIS) is ₹30.41 Cr as of 18th July 2025.What is the 52 week high and low of Genesis IBRC India Ltd (GENESIS) share?
The 52-week high of Genesis IBRC India Ltd (GENESIS) is ₹24.55 and the 52-week low is ₹15.10.What is the PE and PB ratio of Genesis IBRC India Ltd (GENESIS) stock?
The P/E (price-to-earnings) ratio of Genesis IBRC India Ltd (GENESIS) is 8.66. The P/B (price-to-book) ratio is 6.05.Which sector does Genesis IBRC India Ltd (GENESIS) belong to?
Genesis IBRC India Ltd (GENESIS) belongs to the Health Care sector & Biotechnology sub-sector.How to buy Genesis IBRC India Ltd (GENESIS) shares?
You can directly buy Genesis IBRC India Ltd (GENESIS) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Genesis IBRC India Ltd
GENESIS Share Price
24.554.96% (+1.16)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
GENESIS Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
AvgCan be considered moderately valued vs the market
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
BadThe stock is in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
GENESIS Performance & Key Metrics
GENESIS Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 8.69 | 6.05 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 37.08 | 6.54 | 0.76% |
GENESIS Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
GENESIS Company Profile
Genesis IBRC India Ltd develops microbial and antimicrobial products for aquaculture, agriculture, and animal husbandry.
BIOCON
PE Ratio
52.29
52.29
1Y Return
16.19%
16.19%
Buy Reco %
73.33
73.33
ONESOURCE
PE Ratio
-1,276.08
-1,276.08
1Y Return
16.69%
16.69%
Buy Reco %
100.00
100.00
SAILIFE
PE Ratio
100.91
100.91
1Y Return
6.61%
6.61%
Buy Reco %
66.67
66.67
ACUTAAS
PE Ratio
62.34
62.34
1Y Return
82.57%
82.57%
Buy Reco %
100.00
100.00
PANACEABIO
PE Ratio
-320.19
-320.19
1Y Return
216.45%
216.45%
Buy Reco %
0.00
0.00
GENESIS Forecast
GENESIS Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
GENESIS
GENESIS
Income
Balance Sheet
Cash Flow
Annual Normal View
GENESIS Income Statement
GENESIS Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.07 | 0.29 | 0.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.67 | 3.67 | ||||||||||
Raw Materials | 0.00 | 0.25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.16 | 0.17 | ||||||||||
| Power & Fuel Cost | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||
| Employee Cost | 0.00 | 0.05 | 0.02 | 0.01 | 0.04 | 0.04 | 0.01 | 0.04 | ||||||||||||
| Selling & Administrative Expenses | 0.07 | 0.11 | 0.09 | 0.09 | 0.07 | 0.07 | 0.08 | 0.09 | ||||||||||||
| Operating & Other expenses | 0.00 | 0.07 | 0.00 | 0.00 | 0.01 | 0.01 | 0.05 | 3.67 | ||||||||||||
EBITDA | 0.00 | -0.19 | -0.06 | -0.10 | -0.12 | -0.12 | -0.14 | -3.80 | 3.51 | 3.50 | ||||||||||
| Depreciation/Amortization | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||||||
| PBIT | 0.00 | -0.19 | -0.06 | -0.10 | -0.12 | -0.12 | -0.14 | -3.80 | 3.51 | 3.50 | ||||||||||
| Interest & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||||||
| PBT | 0.00 | -0.19 | -0.06 | -0.10 | -0.12 | -0.12 | -0.14 | -3.80 | 3.51 | 3.50 | ||||||||||
| Taxes & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||||||
| Net Income | 0.00 | -0.19 | -0.06 | -0.10 | -0.12 | -0.12 | -0.14 | -3.80 | 3.51 | 3.50 | ||||||||||
| EPS | 0.00 | -0.17 | -0.05 | -0.08 | -0.09 | -0.09 | -0.11 | -2.92 | 2.70 | 2.69 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
GENESIS Company Updates
GENESIS Stock Peers
GENESIS Past Performance & Peer Comparison
GENESIS Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareBiotechnology
Compare valuation-basic on Screener
Health CareBiotechnology
Valuation
Technical
Forecast
Compare valuation-basic on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Genesis IBRC India Ltd | 8.66 | 6.05 | — |
| Biocon Ltd | 52.29 | 2.10 | 0.28% |
| Onesource Specialty Pharma Ltd | -1,276.08 | 57.92 | — |
| Sai Life Sciences Ltd | 100.91 | 17.61 | — |
GENESIS Stock Price Comparison
Compare GENESIS with any stock or ETFCompare GENESIS with any stock or ETF
GENESIS
GENESIS Holdings
GENESIS Shareholdings
GENESIS Promoter Holdings Trend
GENESIS Promoter Holdings Trend
GENESIS Institutional Holdings Trend
GENESIS Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
GENESIS Shareholding Pattern
GENESIS Shareholding Pattern
GENESIS Shareholding History
GENESIS Shareholding History
Foreign Institutions
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing GENESIS stock
smallcases containing GENESIS stock
Looks like this stock is not in any smallcase yet.
GENESIS Events
GENESIS Events
GENESIS Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
GENESIS has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
GENESIS Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
GENESIS has not given any dividends in last 5 years
GENESIS Dividends
GENESIS Dividends
Hmm, looks like data is unavailable here. Please come back after some timeGENESIS Stock News & Opinions
GENESIS Stock News & Opinions
Articles & Videos
Earnings
Genesis IBRC India reports standalone net loss of Rs 0.02 crore in the March 2025 quarter
Net Loss of Genesis IBRC India reported to Rs 0.02 crore in the quarter ended March 2025 as against net loss of Rs 3.69 crore during the previous quarter ended March 2024. There were no Sales reported in the quarter ended March 2025 and during the previous quarter ended March 2024. For the full year,net profit reported to Rs 3.50 crore in the year ended March 2025 as against net loss of Rs 3.80 crore during the previous year ended March 2024. There were no Sales reported in the year ended March 2025 and during the previous year ended March 2024.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Genesis IBRC India to convene board meeting
Genesis IBRC India will hold a meeting of the Board of Directors of the Company on 29 May 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Genesis IBRC India reports standalone net loss of Rs 0.03 crore in the December 2024 quarter
Net Loss of Genesis IBRC India reported to Rs 0.03 crore in the quarter ended December 2024 as against net loss of Rs 0.02 crore during the previous quarter ended December 2023. There were no Sales reported in the quarter ended December 2024 and during the previous quarter ended December 2023.Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Genesis IBRC India to table results
Genesis IBRC India will hold a meeting of the Board of Directors of the Company on 14 February 2025.Powered by Capital Market - Live
5 months agoCapital Market - Live
Earnings
Genesis IBRC India reports standalone net profit of Rs 3.65 crore in the September 2024 quarter
Net profit of Genesis IBRC India reported to Rs 3.65 crore in the quarter ended September 2024 as against net loss of Rs 0.02 crore during the previous quarter ended September 2023. Sales reported to Rs 3.67 crore in the quarter ended September 2024. There were no Sales reported during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales3.670 0 OPM %99.460 - PBDT3.65-0.02 LP PBT3.65-0.02 LP NP3.65-0.02 LP Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Genesis IBRC India schedules board meeting
Genesis IBRC India will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live
8 months agoCapital Market - Live
Earnings
Genesis IBRC India reports standalone net loss of Rs 0.10 crore in the June 2024 quarter
Net Loss of Genesis IBRC India reported to Rs 0.10 crore in the quarter ended June 2024 as against net loss of Rs 0.06 crore during the previous quarter ended June 2023. There were no Sales reported in the quarter ended June 2024 and during the previous quarter ended June 2023.Powered by Capital Market - Live
11 months agoCapital Market - Live
Corporate
Genesis IBRC India announces board meeting date
Genesis IBRC India will hold a meeting of the Board of Directors of the Company on 14 August 2024.Powered by Capital Market - Live
11 months agoCapital Market - Live
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant